D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites
- PMID: 3158731
D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites
Abstract
Striatal D-2 dopamine receptors in homogenates from aged male C57BL/6J mice were examined for high and low-affinity agonist binding. High-affinity dopamine binding requires the ternary complex of the D-2 receptor and a guanine nucleotide binding regulatory protein (N). Thus, changes in the interaction of D-2 and N could contribute to previously reported changes in agonist binding in aged rodents and humans. Qualitative experiments indicated no age-change in the ability of guanine nucleotides to reduce the apparent potency of dopamine at D-2 receptors. Also, no age differences were observed in the ability of guanine nucleotides to decrease N-[3H]propylnorapomorphine binding, suggesting that the ability of guanine nucleotides to dissociate D-2 and N was similar with age. Quantitative determination of the high- (RH) and low-affinity (RL) agonist binding components of striatal D-2 dopamine receptors in the absence of guanine nucleotides indicated differences in the density of RH, and the percentage of D-2 receptors measured as RH, between the ages of 3 and 12 months. No changes in RH or percentage of RH occurred after midlife. In contrast, the total D-2 receptor population, [3H]spiperone maximum binding, declined progressively from 3 to 24 months. Age-changes were restricted to D-2 receptor density; the dissociation constants for agonist and antagonist binding were similar across age. The data suggest that age-changes in striatal D-2 dopamine receptors can occur in the density of the D-2 receptor and in the mechanism that confers the property of high-affinity agonist binding upon the D-2 receptor.
Similar articles
-
Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.Mol Pharmacol. 1988 Apr;33(4):402-13. Mol Pharmacol. 1988. PMID: 3357484
-
Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.J Cereb Blood Flow Metab. 2002 May;22(5):596-604. doi: 10.1097/00004647-200205000-00011. J Cereb Blood Flow Metab. 2002. PMID: 11973432
-
Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.Mol Pharmacol. 1985 Feb;27(2):184-92. Mol Pharmacol. 1985. PMID: 3969067
-
Agonist interactions with dopamine receptors: focus on radioligand-binding studies.Fed Proc. 1984 Oct;43(13):2779-84. Fed Proc. 1984. PMID: 6383871 Review.
-
A comprehensive method for the quantitative determination of dopamine receptor subtypes.Ann N Y Acad Sci. 1984;430:77-90. doi: 10.1111/j.1749-6632.1984.tb14499.x. Ann N Y Acad Sci. 1984. PMID: 6331265 Review.
Cited by
-
Age-related decrease in responsiveness to L-DOPA is not due to changes in dopamine receptor mRNAs or G protein mRNAs.J Neural Transm (Vienna). 1996;103(3):343-8. doi: 10.1007/BF01271245. J Neural Transm (Vienna). 1996. PMID: 8739845
-
Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.Psychopharmacology (Berl). 1987;92(2):236-40. doi: 10.1007/BF00177922. Psychopharmacology (Berl). 1987. PMID: 3110847